` 334970 (Prestige Biologics Co Ltd) vs KOSPI 200 Comparison - Alpha Spread

P
334970
vs
K
KOSPI 200

Over the past 12 months, Prestige Biologics Co Ltd has underperformed KOSPI 200, delivering a return of -37% compared to the KOSPI 200's +114% growth.

Stocks Performance
334970 vs KOSPI 200

Loading
334970
KOSPI 200
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
334970 vs KOSPI 200

Loading
334970
KOSPI 200
Difference
www.alphaspread.com

Performance By Year
334970 vs KOSPI 200

Loading
334970
KOSPI 200
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Prestige Biologics Co Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Prestige Biologics Co Ltd
Glance View

Market Cap
202.2B KRW
Industry
Biotechnology

Prestige Biologics Co., Ltd. engages in research, development, and supplying of pharmaceutical products. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 199 full-time employees. The company went IPO on 2021-03-11. The firm mainly engages in the contract manufacturing service business that produces and supplies biopharmaceuticals; and contract development service business that provides development services including cell culture process and purification process.

Intrinsic Value
2 865.51 KRW
Undervaluation 9%
Intrinsic Value
Price
P
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett